Neuropathy Treatment Centers Of America Inc Phoenix, AZ - 85006

Neuropathy Treatment Centers Of America Inc is categorized under Unclassified in Phoenix, AZ and active since 2011.

Neuropathy Treatment Centers Of America Inc was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Unclassified business, which does work in the B2B market, and is classified as a Unclassified, under code number 561990 by the NAICS.

If you are seeking more information, feel free to contact Joseph O Diduro at the company’s headquarters by writing to 1300 North 12th St # 310, Phoenix, Arizona AZ 85006 or by phoning (602) 663-4808. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Neuropathy Treatment Centers Of America Inc
Contact Person: Joseph O Diduro
Address: 1300 North 12th St # 310, Phoenix, Arizona 85006
Phone Number: (602) 663-4808
Annual Revenue (USD): Unknown
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Unclassified
SIC Code: 7389
NAICS Code: 561990
Share This Business:

Neuropathy Treatment Centers Of America Inc was started in 2011 to provide professional Unclassified under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Joseph O Diduro for inquiries that concern Neuropathy Treatment Centers Of America Inc by calling the company number (602) 663-4808, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Neuropathy Treatment Centers Of America Inc can be found at the coordinates 33.4631,-112.056534 as well as the street address 1300 North 12th St # 310 in Phoenix, Arizona 85006.

For its online presence, you may visit Neuropathy Treatment Centers Of America Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.